Use of State Sequence Analysis in Pharmacoepidemiology: A Tutorial.
data-mining
pharmacoepidemiology
state-sequence analysis
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
20 12 2021
20 12 2021
Historique:
received:
21
10
2021
revised:
14
12
2021
accepted:
16
12
2021
entrez:
24
12
2021
pubmed:
25
12
2021
medline:
31
12
2021
Statut:
epublish
Résumé
While state sequence analysis (SSA) has been long used in social sciences, its use in pharmacoepidemiology is still in its infancy. Indeed, this technique is relatively easy to use, and its intrinsic visual nature may help investigators to untangle the latent information within prescription data, facilitating the individuation of specific patterns and possible inappropriate use of medications. In this paper, we provide an educational primer of the most important learning concepts and methods of SSA, including measurement of dissimilarities between sequences, the application of clustering methods to identify sequence patterns, the use of complexity measures for sequence patterns, the graphical visualization of sequences, and the use of SSA in predictive models. As a worked example, we present an application of SSA to opioid prescription patterns in patients with non-cancer pain, using real-world data from Italy. We show how SSA allows the identification of patterns in prescriptions in these data that might not be evident using standard statistical approaches and how these patterns are associated with future discontinuation of opioid therapy.
Identifiants
pubmed: 34949007
pii: ijerph182413398
doi: 10.3390/ijerph182413398
pmc: PMC8705850
pii:
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Acta Anaesthesiol Scand. 2016 May;60(5):623-33
pubmed: 26861026
Stat Methods Med Res. 2019 Jun;28(6):1731-1740
pubmed: 29742976
Pain. 2013 Nov;154(11):2487-2493
pubmed: 24075311
Demography. 2010 Nov;47(4):1013-34
pubmed: 21308568
Drug Saf. 2018 Feb;41(2):143-149
pubmed: 28840504
Drug Saf. 2019 Mar;42(3):347-363
pubmed: 30269245
Expert Opin Drug Saf. 2017 Jun;16(6):721-732
pubmed: 28490262
J Biopharm Stat. 2015;25(4):843-56
pubmed: 24905478
J Gen Intern Med. 2011 Dec;26(12):1450-7
pubmed: 21751058
Drug Alcohol Depend. 2010 Nov 1;112(1-2):90-8
pubmed: 20634006
Psychopharmacology (Berl). 2016 Jan;233(1):49-56
pubmed: 26407602
Int Clin Psychopharmacol. 2011 Jan;26(1):54-62
pubmed: 20881845
Med Care. 2013 Sep;51(9):789-96
pubmed: 23685406
Stat Methods Med Res. 2019 Jun;28(6):1651-1663
pubmed: 29717944
Fundam Clin Pharmacol. 2011 Aug;25(4):528-33
pubmed: 21729148
Eur Neuropsychopharmacol. 2016 Oct;26(10):1673-7
pubmed: 27593622
Pain. 2015 Apr;156(4):569-576
pubmed: 25785523
Pharmacoepidemiol Drug Saf. 2015 Oct;24(10):1105-13
pubmed: 25903307
Stat Methods Med Res. 2009 Feb;18(1):7-26
pubmed: 18562396
BMC Health Serv Res. 2020 Mar 6;20(1):177
pubmed: 32143702
Ther Adv Drug Saf. 2019 Aug 05;10:2042098619864744
pubmed: 31428307
BMC Health Serv Res. 2015 May 15;15:200
pubmed: 25976089
BMJ Open. 2015 Jan 28;5(1):e007030
pubmed: 25631315
J Sch Health. 2016 Jul;86(7):495-506
pubmed: 27246674
PLoS One. 2019 Jul 16;14(7):e0219717
pubmed: 31310611
Pharmacoepidemiol Drug Saf. 2013 Nov;22(11):1146-53
pubmed: 24030723
Eur J Epidemiol. 2018 Jun;33(6):545-555
pubmed: 29605890
Respirology. 2018 Jun;23(6):583-592
pubmed: 29265705
Br J Clin Pharmacol. 2021 Aug;87(8):3310-3319
pubmed: 33506976
J Popul Res (Canberra). 2008 Oct 1;25(3):287-313
pubmed: 24532990
J Pain Symptom Manage. 2010 Aug;40(2):279-89
pubmed: 20579834
Rev Neurol (Paris). 2021 Dec;177(10):1250-1261
pubmed: 34253346
Biomed Res Int. 2015;2015:217047
pubmed: 26539470
Eur J Epidemiol. 2017 Jul;32(7):567-582
pubmed: 28698923